Becker's Healthcare February 10, 2023
Rylee Wilson

Traditional Medicare and Medicare Advantage beneficiaries could begin seeing lower copays for certain Part B drugs beginning April 1, according to new guidance from HHS.

In a news release published Feb. 9, the agency described the timeline for the implementation of the prescription drug inflation rebate program.

While the periods for which drug companies will have to pay rebates for raising prices have already begun, CMS will not send invoices for these payments until 2025.

Part of the Inflation Reduction Act, the rebate program requires drug manufacturers to pay Medicare rebates for increases in drug costs higher than the rate of inflation.

Here are the key dates HHS laid out:

  • Oct. 1, 2022: The...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, CMS, Govt Agencies, HHS, Insurance, Medicare, Pharma, Pharma / Biotech
Biden administration proposes Medicare coverage for weight loss drugs: 10 things to know
Proposed Coverage of Anti-Obesity Drugs in Medicare and Medicaid Would Expand Access to Millions of People with Obesity
Prior authorizations, pharmacy transparency, vertical integration all part of the Medicare 2026 rule
Medicare and Medicaid would cover Ozempic, Wegovy under new Biden rule
New Proposal Aims to Expand Medicaid and Medicare Coverage for Obesity Drugs

Share This Article